(2) People with certain medical conditions: Due to DSIP's effects on hormone regulation, individuals with Cushing's syndrome or uncontrolled hypertension should avoid use
Step-by-step reconstitution process This process applies to every vial size
Efficacy: What the Head-to-Head Trial Showed In the head-to-head 72-week SURMOUNT-5 trial of 751 adults with obesity without diabetes, tirzepatide reduced body weight by an average of about 20.2% versus 13.7% for semaglutide
By combining licensed medical providers, streamlined digital intake, and reliable home delivery, Refills helps patients access treatment free from extended waiting periods, confusing price models, and the many unnecessary barriers that often prevent people from quickly accessing the care they need
"What's particularly encouraging is that the benefit appears to increase over time rather than fade, and that it behaves like a drug in terms of dose response," Dr Sullivan said, adding that the results give confidence "that we're targeting the right biology"
